Thermo Fisher mycoplasma detection tech accepted for cell therapies

By Flora Southey contact

- Last updated on GMT

GettyImages/man_at_mouse
GettyImages/man_at_mouse
Thermo Fisher Scientific’s mycoplasma detection kit has been accepted by regulators for quality assurance, quality control and lot release.

The Applied Biosystems MycoSEQ Mycoplasma Detection Kit provides manufacturers of cell-culture-based therapeutics a faster method for detecting contamination, said the vendor.

The MycoSEQ assay can detect more than 90 mycoplasma species in less than five hours, offering drugmakers an alternative to “costly, time-consuming culture-based tests often done by externally contract labs, which can take up to 28 days,” ​the firm said.

The assay and method can be used for lot release by drugmakers of biotherapeutics, cell and gene therapies, vaccines, and other cell-culture-based medicines.

Head of pharma analytics Michael Brewer told us the technology was recently granted patents that cover its multiplexed PCR (polymerase chain reaction) primer approach and discriminatory positive/extraction control.

“These innovations to real-time PCR technology, which are unique to us, enable this rapid test for mycoplasma to meet the increasingly rigorous requirements of both regulatory authorities and manufacturers.”

Multiple pharmaceutical companies are using the assay, we were told.

“Several global manufacturers, including Vericel, across multiple therapeutic modalities have successfully validated the assay and achieved regulatory approval for lot release,” ​said Brewer. 

The technology is available to manufacturers worldwide.

Related news

Related products

show more

Microaerobic Fermentation of Lactobacillus acidophilus

Microaerobic Fermentation of Lactobacillus acidophilus

Eppendorf for Bioprocess – Solutions that grow with you | 01-Oct-2019 | Application Note

We successfully performed microaerobic fermenta¬tion of a probiotic strain, Lactobacillus acidophilus, at a very low oxygen level, representing the natural...

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Single-Step Influenza and Dengue Virus Purification

Single-Step Influenza and Dengue Virus Purification

Bio-Rad Laboratories | 08-Oct-2018 | Application Note

CHT XT is the newest addition to the CHT family of media. It has been designed for superior physical robustness to ensure it can be used repeatedly over...

Related suppliers

Follow us

Products

View more

Webinars